http://orcid.org/0000-0002-9421-3087
References
- Ribaldone DG, Pellicano R, Actis GC. The gut and the inflammatory bowel diseases inside-out: the extra-intestinal manifestations. Minerva Gastroenterol Dietol. 2019 DOI:10.23736/S1121-421X.19.02577-7.
- Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55(5):401–412.
- Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20(3):451–471.
- Agrawal D, Rukkannagari S, Kethu S. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol. 2007;53(3):233–248.
- Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–783.
- Feldtkeller E, Khan M, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61–66.
- D’Incà R, Podswiadek M, Ferronato A, et al. Articular manifestations in inflammatory bowel disease patients: a prospective study. Dig Liver Dis. 2009;41:565–569.
- Alnaqbi KA, Touma Z, Passalent L, et al. Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol. 2013;40(10):1726–1735.
- Di Carlo M, Luchetti MM, Benfaremo D, et al. The DETection of Arthritis in Inflammatory bowel diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis. Clin Rheumatol. 2018;37(4):1037–1044.
- Felice C, Leccese P, Scudeller L, et al. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. Clin Exp Immunol. 2019;196(1):123–138.
- Sanz Sanz J, Juanola Roura X, Seoane-Mato D, et al. Criterios de cribado de enfermedad inflamatoria intestinal y espondiloartritis para derivación de pacientes entre Reumatología y Gastroenterología. Reumatol Clín. 2018;14(2):68–74.
- Queiro R, Rodríguez-Caminero S, Riestra S, et al. Performance of two screening questionnaires for inflammatory arthritis in patients with inflammatory bowel disease. Biomed Res Int. 2018;2018:1.
- Suh CH, Lee CH, Lee J, et al. Arthritic manifestations of inflammatory bowel disease. J Korean Med Sci. 1998;13(1):39–43.
- Burlando M, Cozzani E, Schiavetti I, et al. The STRIPP questionnaire (Screening Tool for Rheumatologic Investigation in Psoriatic Patients) as a new tool for the diagnosis of early psoriatic arthritis. G Ital Dermatol Venereol. 2017. DOI:10.23736/S0392-0488.17.05745-5.
- Olivieri I, Cantini F, Castiglione F, et al. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13(8):822–830.
- van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–991.
- Brakenhoff L, van der Heijde DM, Hommes DW, et al. The6 joint–gut axis in inflammatory bowel diseases. J Crohn’s Colitis. 2010;4(3):257–268.
- McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307.
- Subramaniam K, Tymms K, Shadbolt B, et al. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors. Intern Med J. 2015;45(11):1154–1160.
- Buskila D, Odes LR, Neumann L, et al. Fibromyalgia in inflammatory bowel disease. J Rheumatol. 1999;26(5):1167–1171.
- Di Carlo M, Becciolini A, Lato V, et al. The 12-item psoriatic arthritis impact of disease questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol. 2017;44(3):279–285.